Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.

Yamaguchi, Y

Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. [electronic resource] - Pancreas May 1999 - 355-63 p. digital

Publication Type: Journal Article

0885-3177

10.1097/00006676-199905000-00005 doi


Animals
Ceruletide
Chemokines, CXC
Chemotactic Factors--blood
Growth Inhibitors--blood
Growth Substances--blood
Hemorrhage--complications
Intercellular Signaling Peptides and Proteins
Isoquinolines--pharmacology
Kinetics
Lipopolysaccharides--pharmacology
Lung--chemistry
Lung Diseases--complications
Macrophages, Alveolar--drug effects
Male
Pancreatitis--chemically induced
Platelet Activating Factor--antagonists & inhibitors
Platelet Aggregation Inhibitors--pharmacology
Pyridinium Compounds--pharmacology
RNA, Messenger--analysis
Rats
Rats, Wistar
Sepsis--complications
Tetrahydroisoquinolines